Description
Tesofensine is a research compound originally developed as a treatment for neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. However, during clinical trials, it was found to have a significant effect on appetite suppression and weight loss, leading to its investigation as a potential anti-obesity drug.
Mechanism of Action
Tesofensine is a triple monoamine reuptake inhibitor (MRI), meaning it inhibits the reuptake of the neurotransmitters dopamine, norepinephrine, and serotonin in the brain. This results in elevated levels of these neurotransmitters, which can:
- Reduce appetite.
- Increase energy expenditure.
- Improve mood and motivation.
Clinical Research
Studies have shown that Tesofensine can lead to significant weight loss, with reductions in body weight greater than many currently approved weight-loss medications. In one clinical trial, participants lost up to 10-15% of their body weight over six months when combined with dietary and lifestyle interventions.
This PRODUCT IS FOR RESEARCH USE ONLY. This classification permits the use of research chemicals solely for in vitro testing and laboratory experiments. All information about the product provided on this website is intended for educational purposes only. Any introduction of this product into the human or animal body is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not classified as a drug, food, or cosmetic, and must not be misrepresented, misused, or labeled as such.